CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models
出版年份 2023 全文链接
标题
CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 42, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-04
DOI
10.1186/s13046-023-02838-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Surfaceome Profiling of Cell Lines and Patient-Derived Xenografts Confirm FGFR4, NCAM1, CD276, and Highlight AGRL2, JAM3, and L1CAM as Surface Targets for Rhabdomyosarcoma
- (2023) Andrea Timpanaro et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Single-cell profiling of alveolar rhabdomyosarcoma reveals RAS pathway inhibitors as cell-fate hijackers with therapeutic relevance
- (2023) Sara G. Danielli et al. Science Advances
- Inhibitors of the CD73-adenosinergic checkpoint as promising combinatory agents for conventional and advanced cancer immunotherapy
- (2023) Zoya Kurago et al. Frontiers in Immunology
- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Antitumor responses in gastric cancer by targeting B7H3 via chimeric antigen receptor T cells
- (2022) Fengqiang Sun et al. Cancer Cell International
- Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
- (2022) J. Joseph Melenhorst et al. NATURE
- An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials
- (2022) Josephine H. Haduong et al. PEDIATRIC BLOOD & CANCER
- CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours
- (2022) Rebecca C. Larson et al. NATURE
- FGFR4-targeted chimeric antigen receptors (CARs) combined with anti-myeloid poly-pharmacy effectively treats orthotopic rhabdomyosarcoma
- (2022) Peter M. Sullivan et al. MOLECULAR CANCER THERAPEUTICS
- CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
- (2022) Xiaomin Zhang et al. Frontiers in Immunology
- Patient-derived xenografts and organoids model therapy response in prostate cancer
- (2021) Sofia Karkampouna et al. Nature Communications
- CAR-T cell therapy: current limitations and potential strategies
- (2021) Robert C. Sterner et al. Blood Cancer Journal
- A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains
- (2021) Kathryn M. Cappell et al. Nature Reviews Clinical Oncology
- Targeting CD276 by CAR-T cells induces regression of esophagus squamous cell carcinoma in xenograft mouse models
- (2021) Yujing Xuan et al. Translational Oncology
- Surfaceome Profiling of Rhabdomyosarcoma Reveals B7-H3 as a Mediator of Immune Evasion
- (2021) Roxane R. Lavoie et al. Cancers
- GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity
- (2021) Sabine Heitzeneder et al. CANCER CELL
- A High-Throughput Method for Characterizing Novel Chimeric Antigen Receptors in Jurkat Cells
- (2020) Darin Bloemberg et al. Molecular Therapy-Methods & Clinical Development
- Chimeric antigen receptor‐modified T‐cell therapy for platelet‐derived growth factor receptor α‐positive rhabdomyosarcoma
- (2020) Wei Xiao et al. CANCER
- Tuning the Antigen Density Requirement for CAR T-cell Activity
- (2020) Robbie G. Majzner et al. Cancer Discovery
- Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward
- (2020) Leila Jafarzadeh et al. Frontiers in Immunology
- Engineering CAR-T Cells for Next-Generation Cancer Therapy
- (2020) Mihe Hong et al. CANCER CELL
- Phenotypic profiling with a living biobank of primary rhabdomyosarcoma unravels disease heterogeneity and AKT sensitivity
- (2020) Gabriele Manzella et al. Nature Communications
- Efficacy and Safety of CD28- or 4-1BB-Based CD19 CAR-T Cells in B Cell Acute Lymphoblastic Leukemia
- (2020) Xiangyu Zhao et al. Molecular Therapy-Oncolytics
- CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
- (2019) Robbie G. Majzner et al. CLINICAL CANCER RESEARCH
- Rhabdomyosarcoma
- (2019) Stephen X. Skapek et al. Nature Reviews Disease Primers
- Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
- (2019) Hongwei Du et al. CANCER CELL
- A safe and potent anti-CD19 CAR T cell therapy
- (2019) Zhitao Ying et al. NATURE MEDICINE
- Emerging trends in immunotherapy for pediatric sarcomas
- (2019) Kyle A. Dyson et al. Journal of Hematology & Oncology
- Gene editing for immune cell therapies
- (2019) Stefanie R. Bailey et al. NATURE BIOTECHNOLOGY
- B7-H3 as a novel CAR-T therapeutic target for glioblastoma
- (2019) Xin Tang et al. Molecular Therapy-Oncolytics
- Parallel comparison of 4-1BB or CD28 co-stimulated CD19-targeted chimeric antigen receptor-T cells for B-cell non-Hodgkin lymphoma
- (2019) Zhitao Ying et al. Molecular Therapy-Oncolytics
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- Hedgehog Pathway Drives Fusion-Negative Rhabdomyosarcoma Initiated From Non-myogenic Endothelial Progenitors
- (2018) Catherine J. Drummond et al. CANCER CELL
- Induction of a central memory and stem cell memory phenotype in functionally active CD4+ and CD8+ CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19+ acute lymphoblastic leukemia
- (2018) Franziska Blaeschke et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Development and Evaluation of an Optimal Human Single-Chain Variable Fragment-Derived BCMA-Targeted CAR T Cell Vector
- (2018) Eric L. Smith et al. MOLECULAR THERAPY
- Chimeric Antigen Receptor Therapy
- (2018) Carl H. June et al. NEW ENGLAND JOURNAL OF MEDICINE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- In vivo fate and activity of second versus third-generation D19-specific CAR-T cells in B-cell non-Hodgkin lymphomas
- (2018) Carlos A. Ramos et al. MOLECULAR THERAPY
- Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function
- (2018) Alexander I. Salter et al. Science Signaling
- TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action
- (2017) Wenwen Du et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase
- (2017) Alec J. Walker et al. MOLECULAR THERAPY
- GUIDES: sgRNA design for loss-of-function screens
- (2017) Joshua A Meier et al. NATURE METHODS
- Generation and characterization of ErbB2-CAR-engineered cytokine-induced killer cells for the treatment of high-risk soft tissue sarcoma in children
- (2017) Michael Merker et al. Oncotarget
- Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
- (2016) Omkar U. Kawalekar et al. IMMUNITY
- BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models
- (2016) Yuki Kagoya et al. JOURNAL OF CLINICAL INVESTIGATION
- 649. Developing FGFR4 Chimeric Antigen Receptor CAR T Cell Therapy Against Rhabdomyosarcoma
- (2016) Nityashree Shivaprasad et al. MOLECULAR THERAPY
- Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells
- (2016) Godehard Scholz et al. EBioMedicine
- Cellular immunotherapy for pediatric solid tumors
- (2015) Meenakshi Hegde et al. CYTOTHERAPY
- CAR T-cell therapy: toxicity and the relevance of preclinical models
- (2015) Milena Kalaitsidou et al. Immunotherapy
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- The pharmacology of second-generation chimeric antigen receptors
- (2015) Sjoukje J. C. van der Stegen et al. NATURE REVIEWS DRUG DISCOVERY
- In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells
- (2015) Luca Biasco et al. Science Translational Medicine
- IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas
- (2015) Xin Huang et al. PLoS One
- Classification of Rhabdomyosarcoma and Its Molecular Basis
- (2013) David M. Parham et al. ADVANCES IN ANATOMIC PATHOLOGY
- Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
- (2013) M. Hudecek et al. CLINICAL CANCER RESEARCH
- Design and development of therapies using chimeric antigen receptor-expressing T cells
- (2013) Gianpietro Dotti et al. IMMUNOLOGICAL REVIEWS
- B7-H3 is Overexpressed in Patients Suffering Osteosarcoma and Associated with Tumor Aggressiveness and Metastasis
- (2013) Ling Wang et al. PLoS One
- A Mouse Model of Rhabdomyosarcoma Originating from the Adipocyte Lineage
- (2012) Mark E. Hatley et al. CANCER CELL
- FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma
- (2012) L. E. S. Crose et al. CLINICAL CANCER RESEARCH
- B7-H3, a potential therapeutic target, is expressed in diffuse intrinsic pontine glioma
- (2012) Zhiping Zhou et al. JOURNAL OF NEURO-ONCOLOGY
- Evidence for an Unanticipated Relationship between Undifferentiated Pleomorphic Sarcoma and Embryonal Rhabdomyosarcoma
- (2011) Brian P. Rubin et al. CANCER CELL
- Alveolar rhabdomyosarcoma: Is the cell of origin a mesenchymal stem cell?
- (2008) Elizabeth Charytonowicz et al. CANCER LETTERS
- Adoptive transfer of effector CD8+ T cells derived from central memory cells establishes persistent T cell memory in primates
- (2008) Carolina Berger et al. JOURNAL OF CLINICAL INVESTIGATION
- A One Pot, One Step, Precision Cloning Method with High Throughput Capability
- (2008) Carola Engler et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now